Report Overview

Middle East and Africa Stem Cell Therapy Market – Industry Trends & Forecast Report, 2030

The Middle East and Africa Stem Cell Therapy Market size was estimated at USD1.67 billion in 2023. During the forecast period between 2024 and 2030, the Middle East and Africa Stem Cell Therapy Market size is projected to grow at a CAGR of 5.43% reaching a value of USD 2.45 billion by 2030. A prominent driver of the market is increasing research and advancements in stem cell therapy. The Middle East and Africa have become focal points for extensive stem cell research, with a particular emphasis on unlocking the therapeutic potential of stem cells across various medical domains. Notably, innovative techniques such as stem cell injections are being explored alongside traditional methodologies, promising significant advancements in regenerative medicine and tissue engineering. For instance, stem cell therapy targeting knee ailments aims to address issues like osteoarthritis by repairing damaged tissues and alleviating associated pain. Also, the advent of sophisticated stem cell technologies has been instrumental, facilitating the isolation, expansion, and manipulation of stem cells for therapeutic purposes. Technological progress has led to improved treatment outcomes and expanded the scope of stem cell-based interventions in the region. Consequently, the Middle East and Africa stem cell market are experiencing steady growth, driven by the rising adoption of stem cell therapy across diverse medical disciplines, including neurodegenerative disorders, cardiovascular diseases, and orthopedic condition.

Stem Cell Therapy – Overview

Stem cell therapy is a medical treatment that harnesses the regenerative potential of stem cells to repair, replace, or restore damaged tissues and organs within the body. Stem cells, which are undifferentiated cells capable of developing into various cell types, can be derived from different sources, such as embryos, adult tissues, or induced pluripotent stem cells (iPSCs). In stem cell therapy, these versatile cells are utilized to stimulate tissue regeneration, modulate the immune system, and promote healing in conditions ranging from degenerative diseases to injuries. This therapeutic approach holds promise for treating a wide range of medical conditions, including neurological disorders, cardiovascular diseases, orthopedic injuries, and autoimmune disorders, among others.

Middle East and Africa Stem Cell Therapy Market

Growth Drivers

Rising Prevalence of Chronic Diseases

The escalating occurrence of chronic ailments constitutes a significant catalyst propelling the Stem Cell Market in the Middle East and Africa region. With the population expanding and aging in this region, there is a notable uptick in conditions like cardiovascular diseases, orthopedic issues, and neurodegenerative disorders. Stem cell therapy emerges as a promising remedy for these afflictions, offering the prospect of tissue regeneration and sustained alleviation. This burgeoning demand for efficacious treatment modalities, complemented by progressions in stem cell research and supportive governmental policies, fuels the uptake of stem cell therapies across Middle East and Africa.

Growing Demand for Regenerative Treatment Options

In the Middle East and North Africa (MENA) region, the demand for regenerative treatment options is rapidly increasing, fueled by the promising advancements in stem cell therapy and regenerative medicine. With the region poised to become a global center for biomedical research, events like the MENA Stem Cells Forum serve as vital platforms for discussing key trends and topics, including stem cell banking and scientific research. The forum, held in Dubai, attracts renowned experts and stakeholders to share insights on the latest advancements and challenges in stem cell research and therapy. Such initiatives reflect the growing need for innovative regenerative treatment options in the region.

Challenges

High Costs of Stem Cell Therapies

The soaring expenses associated with stem cell therapies pose a significant impediment to the growth of Middle East and Africa Stem Cell Therapy Market. These prohibitive costs create barriers to access for patients in the region, limiting the market's expansion potential. Despite the region's growing interest and advancements in stem cell therapy, the high financial burden hampers widespread adoption. Consequently, the market faces challenges in reaching its full growth trajectory. Addressing the issue of affordability is crucial for unlocking the market's potential and ensuring equitable access to stem cell therapies across Middle East and Africa.

Impact of Geopolitical Tensions on Middle East and Africa Stem Cell Therapy Market

Geopolitical tensions in the Middle East and Africa region exert a notable impact on the Stem Cell Therapy Market, disrupting investment flows, research collaborations, and regulatory frameworks. Uncertainties stemming from geopolitical conflicts create hurdles for market players, deterring potential investors and impeding the growth of the industry. Moreover, such tensions can disrupt supply chains, affecting the availability of essential resources for stem cell research and therapy. Consequently, the market growth is hindered, necessitating strategic efforts to mitigate geopolitical risks and foster stability for sustained development in stem cell therapies across Middle East and Africa.

Middle East and Africa Stem Cell Therapy Market

Segmental Coverage

Middle East and Africa Stem Cell Therapy Market – By Type

By type, the Middle East and Africa Stem Cell Therapy Market is bifurcated into Allogenic Stem Cell Therapy and Autologous Steam Cell Therapy segments. The autologous stem cell therapy segment holds a higher share in the Middle East and Africa Stem Cell Therapy Market by type. Autologous stem cell therapy involves utilizing a patient's own stem cells, which are collected, processed, and reintroduced into the patient's body for therapeutic purposes. This method offers numerous benefits, such as reduced risk of immune rejection and graft-versus-host disease since the patient's cells are utilized. Furthermore, it eliminates the necessity for immunosuppressive drugs, enhancing safety. Additionally, obtaining stem cells from patients is more accessible and available compared to other sources, contributing to the dominance of autologous stem cell therapy in the region. Meanwhile, the allogenic steam cell therapy is expected to witness the fastest growth rate during the forecast period. Allogeneic stem cell therapy employs donor-derived stem cells, providing advantages like accessibility and broader patient applicability. It enables the creation of standardized products, enhancing convenience and cost-effectiveness. Advancements in immunosuppression techniques reduce the risk of adverse immune reactions, further driving the growth of allogeneic stem cell therapy.

Middle East and Africa Stem Cell Therapy Market – By Cell Source

Based on cell source, the Middle East and Africa Stem Cell Therapy Market is divided into Adipose Tissue-Derived MSCs, Bone Marrow-derived MSCs, and Placental/Umbilical Cord-derived MSCs segments. The bone marrow-derived MSCs segment holds the highest share in the Middle East and Africa Stem Cell Therapy Market by cell source. Bone marrow-derived mesenchymal stem cells emerge as the leading segment in the Middle East and Africa stem cell therapy market due to several reasons. Extensive research has solidified their status as a validated treatment option, with demonstrated clinical efficacy and safety across various applications like regenerative medicine and immunotherapy. Additionally, their accessibility, abundance, and versatile differentiation potential underscore their widespread clinical adoption.

Middle East and Africa Stem Cell Therapy Market – By Therapeutic Application

On the basis of therapeutic application, the Middle East and Africa Stem Cell Therapy Market is divided into Musculoskeletal Disorders, Wounds & Surgeries, Cardiovascular Diseases, Inflammatory & Autoimmune, and Neurological Disorders segments. The musculoskeletal segment holds the highest share in the Middle East and Africa Stem Cell Therapy Market by therapeutic application. It can be attributed to the prevalence of musculoskeletal disorders in the region, such as osteoarthritis and bone fractures, driving the demand for stem cell treatments. Additionally, advancements in regenerative medicine techniques targeting musculoskeletal issues further bolster the segment's prominence.

Middle East and Africa Stem Cell Therapy Market – By Country

The in-depth research report on the Middle East and Africa Stem Cell Therapy Market covers the market in the region’s major countries including Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, and Rest of MEA. The UAE holds the highest share in the Middle East and Africa Stem Cell Therapy Market. The UAE has positioned itself as a significant center for medical tourism, boasting advanced healthcare facilities. Through substantial investments in stem cell research and therapy, it has become a destination for patients globally seeking cutting-edge treatments. The UAE hosts modern stem cell clinics providing diverse therapies for orthopedic, neurological, and cardiovascular conditions. Its supportive regulatory landscape and partnerships with top global research entities have solidified its leadership in the stem cell market. Meanwhile, South Africa is expected to record the fastest growth rate over the forecast period. With a robust healthcare system and an increasing emphasis on regenerative medicine, South Africa is deeply engaged in stem cell research. Its exploration spans across various diseases like HIV/AIDS, diabetes, and spinal cord injuries. Government backing and the presence of prestigious research centers and universities have propelled South Africa's prominence in the global stem cell arena.

Competitive Landscape

Major players operating in Middle East and Africa Stem Cell Therapy Market include Acell, Stem Cells for Life, Ncardia, Thermo Fisher Scientific, Inc., STEMCELL Technologies Inc., Merck KGaA, CellGenix GmbH, Takara Bio, Lonza, Cellartis AB, ATCC, and Bio-Techne. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In March 2023 - Bristol Myers Squibb made a USD 200-million investment in Fate Therapeutics to bolster the clinical advancement and commercialization efforts of Fate Therapeutics' off-the-shelf cell therapies.

Scope of the Report

By Type

• Allogenic Stem Cell Therapy

• Autologous Stem Cell Therapy

By Cell Source

• Adipose Tissue-Derived MSCs

• Bone Marrow-derived MSCs

• Placental/Umbilical Cord-derive MSCs

By Therapeutic Application

• Musculoskeletal Disorders

• Wounds & Surgeries

• Cardiovascular Diseases

• Inflammatory & Autoimmune

• Neurological Disorders

By Country

• Saudi Arabia

• UAE

• Qatar

• Kuwait

• South Africa

• Nigeria

• Algeria

• Rest of MEA

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Executive Summary
3. Middle East and Africa Stem Cell Therapy Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
         1. Rising prevalence of chronic diseases
         2. Increasing government funding for stem cell research
         3. Technological advancements in stem cell therapeutics
         4. Growing demand for regenerative treatment options
      2. Restraints
         1. Ethical concerns related to embryonic stem cells
         2. High costs of stem cell therapies
      3. Opportunities
         1. Rising awareness about stem cell banking
         2. Increasing focus on developing personalized medicines
      4. Challenges
         1. Technical limitations
         2. Safety concerns
   3. Technological Advancements/Recent Developments
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4. Middle East and Africa Stem Cell Therapy Market: Marketing Strategies
5. Middle East and Africa Stem Cell Therapy Market: Pricing Analysis
6. Middle East and Africa Stem Cell Therapy Market Overview
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
         1. Allogenic Stem Cell Therapy
         2. Autologous Stem Cell Therapy
      2. By Cell Source
         1. Adipose Tissue-Derived MSCs
         2. Bone Marrow-derived MSCs
         3. Placental/Umbilical Cord-derive MSCs
         4. Ohers
      3. By Therapeutic Application
         1. Musculoskeletal Disorders
         2. Wounds & Surgeries
         3. Cardiovascular Diseases
         4. Inflammatory & Autoimmune
         5. Neurological Disorders
         6. Others
      4. By Country
         1. Saudi Arabia
         2. UAE
         3. Qatar
         4. Kuwait
         5. South Africa
         6. Nigeria
         7. Algeria
         8. Rest of MEA
7. Saudi Arabia Stem Cell Therapy Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
      2. By Cell Source
      3. By Therapeutic Application
8. UAE Stem Cell Therapy Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
      2. By Cell Source
      3. By Therapeutic Application
9. Qatar Stem Cell Therapy Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
      2. By Cell Source
      3. By Therapeutic Application
10. Kuwait Stem Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Therapeutic Application
11. South Africa Stem Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Therapeutic Application
12. Nigeria Stem Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Therapeutic Application
13. Algeria Stem Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Therapeutic Application
14. Rest of MEA Stem Cell Therapy Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Therapeutic Application
15. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Middle East and Africa Stem Cell Therapy Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
16. Impact of Geopolitical Tensions on Middle East and Africa Stem Cell Therapy Market
17. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Acell
    2. Stem Cells for Life
    3. Ncardia
    4. Thermo Fisher Scientific, Inc.
    5. STEMCELL Technologies Inc.
    6. Merck KGaA
    7. CellGenix GmbH
    8. Takara Bio
    9. Lonza
    10. Cellartis AB
    11. ATCC
    12. Bio-Techne
    13. Other Prominent Players
18. Key Strategic Recommendations
19. Research Methodology
    1.       Qualitative Research
       1.   Primary & Secondary Research
    2.       Quantitative Research
    3.       Market Breakdown & Data Triangulation
       1.   Secondary Research
       2.   Primary Research
    4.       Breakdown of Primary Research Respondents, By Country
    5.       Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1       Middle East and Africa Stem Cell Therapy Segmentation

Figure 2       Middle East and Africa Stem Cell Therapy Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       Middle East and Africa Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 5       Middle East and Africa Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 6       Middle East and Africa Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 7       Middle East and Africa Stem Cell Therapy Market Share, By Therapeutic Application, By Value, 2019–2030

Figure 8       Middle East and Africa Stem Cell Therapy Market Share, By Country, By Value, 2019–2030

Figure 9       Saudi Arabia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 10     Saudi Arabia Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 11     Saudi Arabia Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 12     Saudi Arabia Stem Cell Therapy Market Share, By Therapeutic Application, By Value, 2019–2030

Figure 13     UAE Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 14     UAE Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 15     UAE Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 16     UAE Stem Cell Therapy Market Share, By Therapeutic Application, By Value, 2019–2030

Figure 17     Qatar Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 18     Qatar Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 19     Qatar Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 20     Qatar Stem Cell Therapy Market Share, By Therapeutic Application, By Value, 2019–2030

Figure 21     Kuwait Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 22     Kuwait Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 23     Kuwait Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 24     Kuwait Stem Cell Therapy Market Share, By Therapeutic Application, By Value, 2019–2030

Figure 25     South Africa Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 26     South Africa Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 27     South Africa Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 28     South Africa Stem Cell Therapy Market Share, By Therapeutic Application, By Value, 2019–2030

Figure 29     Nigeria Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 30     Nigeria Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 31     Nigeria Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 32     Nigeria Stem Cell Therapy Market Share, By Therapeutic Application, By Value, 2019–2030

Figure 33     Algeria Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 34     Algeria Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 35     Algeria Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 36     Algeria Stem Cell Therapy Market Share, By Therapeutic Application, By Value, 2019–2030

Figure 37     Rest of MEA Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 38     Rest of MEA Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 39     Rest of MEA Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 40     Rest of MEA Stem Cell Therapy Market Share, By Therapeutic Application, By Value, 2019–2030

List of Tables

Table 1        Middle East and Africa Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030 

Table 2        Middle East and Africa Stem Cell Therapy Market Size, By Type, By Value, 2019–2030 

Table 3        Middle East and Africa Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030 

Table 4        Middle East and Africa Stem Cell Therapy Market Size, By Therapeutic Application, By Value, 2019–2030     

Table 5        Middle East and Africa Stem Cell Therapy Market Size, By Country, By Value, 2019–2030 

Table 6        Saudi Arabia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 7        Saudi Arabia Stem Cell Therapy Market Size, By Type, By Value, 2019–2030 

Table 8        Saudi Arabia Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030 

Table 9        Saudi Arabia Stem Cell Therapy Market Size, By Therapeutic Application, By Value, 2019–2030

Table 10      UAE Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030       

Table 11      UAE Stem Cell Therapy Market Size, By Type, By Value, 2019–2030    

Table 12      UAE Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030    

Table 13      UAE Stem Cell Therapy Market Size, By Therapeutic Application, By Value, 2019–2030 

Table 14      Qatar Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030     

Table 15      Qatar Stem Cell Therapy Market Size, By Type, By Value, 2019–2030 

Table 16      Qatar Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030 

Table 17      Qatar Stem Cell Therapy Market Size, By Therapeutic Application, By Value, 2019–2030 

Table 18      Kuwait Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030   

Table 19      Kuwait Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 20      Kuwait Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 21      Kuwait Stem Cell Therapy Market Size, By Therapeutic Application, By Value, 2019–2030 

Table 22      South Africa Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 23      South Africa Stem Cell Therapy Market Size, By Type, By Value, 2019–2030 

Table 24      South Africa Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030         

Table 25      South Africa Stem Cell Therapy Market Size, By Therapeutic Application, By Value, 2019–2030 

Table 26      Nigeria Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030   

Table 27      Nigeria Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 28      Nigeria Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 29      Nigeria Stem Cell Therapy Market Size, By Therapeutic Application, By Value, 2019–2030 

Table 30      Algeria Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030   

Table 31      Algeria Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 32      Algeria Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 33      Algeria Stem Cell Therapy Market Size, By Therapeutic Application, By Value, 2019–2030 

Table 34      Rest of MEA Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030         

Table 35      Rest of MEA Stem Cell Therapy Market Size, By Type, By Value, 2019–2030  

Table 36      Rest of MEA Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030         

Table 37      Rest of MEA Stem Cell Therapy Market Size, By Therapeutic Application, By Value, 2019–2030 

Table 38      Acell Company Overview

Table 39      Acell Financial Overview

Table 40      Stem Cells for Life Company Overview

Table 41      Stem Cells for Life Financial Overview

Table 42      Ncardia Company Overview

Table 43      Ncardia Financial Overview

Table 44      Thermo Fisher Scientific, Inc. Company Overview

Table 45      Thermo Fisher Scientific, Inc. Financial Overview

Table 46      STEMCELL Technologies Inc. Company Overview

Table 47      STEMCELL Technologies Inc. Financial Overview

Table 48      Merck KGaA Company Overview

Table 49      Merck KGaA Financial Overview

Table 50      CellGenix GmbH Company Overview

Table 51      CellGenix GmbH Financial Overview

Table 52      Takara Bio Company Overview

Table 53      Takara Bio Financial Overview

Table 54      Lonza Company Overview

Table 55      Lonza Financial Overview

Table 56      Cellartis AB Company Overview

Table 57      Cellartis AB Financial Overview

Table 58      ATCC Company Overview

Table 59      ATCC Financial Overview

Table 60      Bio-Techne Company Overview

Table 61      Bio-Techne Financial Overview